Light Glymeperide Tablet 1/250mg

Adult dose

This medication is administered 1-2 times a day before meals or with meals. The dose can be adjusted based on each patient's current treatment regimen, efficacy, and tolerance, with appropriate blood glucose monitoring conducted. Usually, treatment begins at a low dose, and adjustments can be made considering the current medications and blood glucose levels of the patient. In clinical trials, the initial daily dose was glymeperide/metformin hydrochloride.

This medication may cause severe lactic acidosis or hypoglycemia; therefore, caution is needed. Especially, if renal function rapidly declines, the drug may accumulate in the body increasing the risk of lactic acidosis. If dehydration, severe diarrhea, vomiting, or fever occurs, temporarily stop taking and consult a physician. Additionally, because the risk of death related to cardiovascular disease may increase, cardiovascular health should be monitored closely during this medication. Patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver or kidney dysfunction, and women who are pregnant or breastfeeding should not use this medication. Elderly patients, malnourished individuals, those with irregular meals, and those who consume excessive alcohol should be particularly cautious while taking this. Gastrointestinal symptoms (diarrhea, nausea, vomiting, etc.) may occur at the beginning of treatment, but these symptoms are usually temporary. If symptoms such as allergic reactions, skin rashes, or breathing difficulties occur, inform a physician immediately. This medication can interact with other drugs, so it is essential to inform healthcare providers about any other medications being taken. Regular monitoring of blood glucose, renal function, and blood tests is important. In cases of overdose, symptoms of hypoglycemia may appear, requiring immediate medical assistance, and if necessary, blood dialysis may be performed to remove the drug. It is safest for pregnant or breastfeeding women not to take this medication and to switch to insulin therapy for blood glucose control. Caution is necessary while driving or operating machinery due to the risk of accidents from hypoglycemia or dizziness. The safety and efficacy of this medication have not been established in children, so caution should be exercised in their use. Medications should be stored out of reach of children, and care should be taken not to transfer them to other containers.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, hypotension, shock, liver dysfunction (including jaundice), confusion, seizures, paralysis, severe hypoglycemia, lactic acidosis, renal dysfunction, severe hematological abnormalities (leukopenia, hemolytic anemia, agranulocytosis, pancytopenia), cardiac arrest

Mild side effects

Gastrointestinal symptoms (diarrhea, nausea, vomiting, abdominal bloating, loss of appetite, indigestion, constipation, abdominal pain), metallic taste, visual impairment, palpitations, dizziness, light-headedness, prostatic hyperplasia, thrombocytopenia, decreased vitamin B12, increased liver enzymes, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium, facial edema, erectile dysfunction, hair loss, facial flushing, gastritis

This medication should be stored in a tightly closed container to prevent air from entering, at room temperature between 1°C and 30°C. Storing it this way helps maintain the drug's effectiveness.

Appearance

White oblong film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle